|
ATMIN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.12999999649588E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.06480005210597E-09 |
| Normal-vs-Stage2 |
1.338300E-02 |
| Normal-vs-Stage3 |
5.273400E-01 |
| Normal-vs-Stage4 |
8.113600E-02 |
| Stage1-vs-Stage2 |
3.827000E-01 |
| Stage1-vs-Stage3 |
2.261100E-03 |
| Stage1-vs-Stage4 |
8.028600E-01 |
| Stage2-vs-Stage3 |
1.492580E-01 |
| Stage2-vs-Stage4 |
7.493800E-01 |
| Stage3-vs-Stage4 |
1.723010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.99300000234015E-08 |
| Normal-vs-AfricanAmerican |
1.212990E-04 |
| Normal-vs-Asian |
9.756200E-01 |
| Caucasian-vs-AfricanAmerican |
9.352600E-01 |
| Caucasian-vs-Asian |
1.150180E-01 |
| AfricanAmerican-vs-Asian |
1.856810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.80340006553593E-10 |
| Normal-vs-Female |
8.477600E-02 |
| Male-vs-Female |
7.783600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.020260E-04 |
| Normal-vs-Extreme_Weight |
9.62059987230646E-10 |
| Normal-vs-Obese |
4.763800E-03 |
| Normal-vs-Extreme_Obese |
1.002290E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.631600E-01 |
| Normal_Weight-vs-Obese |
1.463210E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.545600E-01 |
| Extreme_Weight-vs-Obese |
8.982300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.488800E-01 |
| Obese-vs-Extreme_Obese |
9.863800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.166200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.6076000000016E-05 |
| Normal-vs-Age(61-80Yrs) |
6.12619999174058E-09 |
| Normal-vs-Age(81-100Yrs) |
1.55599999995815E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.343360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.690130E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.915100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.329500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.795900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.108200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.75890002352253E-10 |
| Normal-VS-Type2 PRCC |
2.427100E-04 |
| Normal-VS-KIRP CIMP |
4.704800E-01 |
| Normal-VS-Unclassified PRCC |
4.686300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.089400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.448800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.220300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.967680E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.288400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.393500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.93582999999942E-05 |
| Normal-vs-N1 |
8.471400E-01 |
| Normal-vs-N2 |
2.14439999999261E-05 |
| N0-vs-N1 |
7.700800E-03 |
| N0-vs-N2 |
3.003800E-01 |
| N1-vs-N2 |
4.384300E-02 |
|
|
